Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Homo sapiens | ATPase family, AAA domain containing 5 | Starlite/ChEMBL | No references |
Homo sapiens | isocitrate dehydrogenase 1 (NADP+), soluble | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.0216 | 0.0479 |
Mycobacterium ulcerans | thymidylate synthase | 0.0109 | 0.0879 | 0.2822 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.0022 | 0.005 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0066 | 0.0457 | 0.0527 |
Loa Loa (eye worm) | hypothetical protein | 0.048 | 0.4508 | 1 |
Echinococcus multilocularis | thymidylate synthase | 0.0109 | 0.0879 | 0.0879 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0066 | 0.0457 | 0.0527 |
Schistosoma mansoni | hypothetical protein | 0.0021 | 0.0022 | 0.0026 |
Schistosoma mansoni | hypothetical protein | 0.0906 | 0.8677 | 1 |
Toxoplasma gondii | kinesin motor domain-containing protein | 0.0135 | 0.1137 | 0.5783 |
Mycobacterium tuberculosis | Probable thymidylate synthase ThyA (ts) (TSASE) | 0.0109 | 0.0879 | 0.4502 |
Plasmodium falciparum | kinesin-5 | 0.0135 | 0.1137 | 0.5783 |
Plasmodium vivax | multidomain scavenger receptor, putative | 0.0021 | 0.0022 | 0.0114 |
Echinococcus multilocularis | RUN | 0.0021 | 0.0022 | 0.0022 |
Brugia malayi | hypothetical protein | 0.0052 | 0.032 | 0.0711 |
Brugia malayi | hypothetical protein | 0.0021 | 0.0022 | 0.005 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.0216 | 0.0249 |
Onchocerca volvulus | 0.048 | 0.4508 | 1 | |
Echinococcus multilocularis | Protein lozenge | 0.006 | 0.0402 | 0.0402 |
Plasmodium vivax | bifunctional dihydrofolate reductase-thymidylate synthase, putative | 0.022 | 0.1966 | 1 |
Echinococcus multilocularis | atpase aaa+ type core atpase aaa type core | 0.0979 | 0.9391 | 0.9391 |
Brugia malayi | Kinesin motor domain containing protein | 0.0135 | 0.1137 | 0.2521 |
Loa Loa (eye worm) | dihydrofolate reductase | 0.0219 | 0.1953 | 0.4331 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.0402 | 0.0892 |
Mycobacterium leprae | DIHYDROFOLATE REDUCTASE DFRA (DHFR) (TETRAHYDROFOLATE DEHYDROGENASE) | 0.0219 | 0.1953 | 1 |
Toxoplasma gondii | bifunctional dihydrofolate reductase-thymidylate synthase | 0.022 | 0.1966 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.0402 | 0.0892 |
Plasmodium vivax | kinesin-5 | 0.0135 | 0.1137 | 0.5783 |
Loa Loa (eye worm) | hypothetical protein | 0.048 | 0.4508 | 1 |
Echinococcus granulosus | arachidonate 5 lipoxygenase | 0.006 | 0.0399 | 0.0399 |
Mycobacterium ulcerans | dihydrofolate reductase DfrA | 0.0219 | 0.1953 | 1 |
Schistosoma mansoni | lozenge | 0.006 | 0.0402 | 0.0464 |
Echinococcus multilocularis | lipoxygenase domain containing protein | 0.0021 | 0.0022 | 0.0022 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0402 | 0.0892 |
Schistosoma mansoni | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0109 | 0.0879 | 0.1013 |
Loa Loa (eye worm) | doublecortin family protein | 0.0021 | 0.0022 | 0.005 |
Echinococcus multilocularis | arachidonate 5 lipoxygenase | 0.006 | 0.0399 | 0.0399 |
Schistosoma mansoni | lipoxygenase | 0.0021 | 0.0022 | 0.0026 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0066 | 0.0457 | 0.2325 |
Plasmodium falciparum | LCCL domain-containing protein | 0.0021 | 0.0022 | 0.0114 |
Mycobacterium tuberculosis | Dihydrofolate reductase DfrA (DHFR) (tetrahydrofolate dehydrogenase) | 0.0219 | 0.1953 | 1 |
Schistosoma mansoni | rab6-interacting | 0.0021 | 0.0022 | 0.0026 |
Brugia malayi | dihydrofolate reductase family protein | 0.0219 | 0.1953 | 0.4331 |
Plasmodium falciparum | bifunctional dihydrofolate reductase-thymidylate synthase | 0.022 | 0.1966 | 1 |
Entamoeba histolytica | kinesin, putative | 0.0135 | 0.1137 | 0.5 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0066 | 0.0457 | 0.0457 |
Echinococcus multilocularis | dihydrofolate reductase | 0.0219 | 0.1953 | 0.1953 |
Loa Loa (eye worm) | runx1 | 0.006 | 0.0402 | 0.0892 |
Trypanosoma brucei | dihydrofolate reductase-thymidylate synthase | 0.022 | 0.1966 | 1 |
Echinococcus multilocularis | lipoxygenase domain containing protein | 0.0021 | 0.0022 | 0.0022 |
Chlamydia trachomatis | dihydrofolate reductase | 0.0219 | 0.1953 | 0.5 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0028 | 0.0091 | 0.0201 |
Loa Loa (eye worm) | kinesin-like protein KLP2 | 0.0135 | 0.1137 | 0.2521 |
Echinococcus granulosus | Polycystic kidney disease protein | 0.0021 | 0.0022 | 0.0022 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0066 | 0.0457 | 0.0457 |
Echinococcus granulosus | dihydrofolate reductase | 0.0219 | 0.1953 | 0.1953 |
Schistosoma mansoni | dihydrofolate reductase | 0.0219 | 0.1953 | 0.2251 |
Echinococcus granulosus | thymidylate synthase | 0.0109 | 0.0879 | 0.0879 |
Schistosoma mansoni | rab6-interacting | 0.0021 | 0.0022 | 0.0026 |
Echinococcus multilocularis | Polycystic kidney disease protein | 0.0021 | 0.0022 | 0.0022 |
Schistosoma mansoni | lipoxygenase | 0.006 | 0.0399 | 0.0459 |
Brugia malayi | thymidylate synthase | 0.0109 | 0.0879 | 0.195 |
Echinococcus multilocularis | kinesin family 1 | 0.1041 | 1 | 1 |
Mycobacterium tuberculosis | Hypothetical protein | 0.0052 | 0.032 | 0.1641 |
Brugia malayi | hypothetical protein | 0.048 | 0.4508 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.0022 | 0.005 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0052 | 0.032 | 0.5 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.0066 | 0.0457 | 0.234 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.0216 | 0.0479 |
Brugia malayi | Cytochrome P450 family protein | 0.0028 | 0.0091 | 0.0201 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase | 0.022 | 0.1966 | 1 |
Brugia malayi | hypothetical protein | 0.0021 | 0.0022 | 0.005 |
Brugia malayi | Dihydrofolate reductase | 0.0219 | 0.1953 | 0.4331 |
Schistosoma mansoni | kinesin eg-5 | 0.0135 | 0.1137 | 0.131 |
Brugia malayi | Doublecortin family protein | 0.0021 | 0.0022 | 0.005 |
Onchocerca volvulus | 0.0109 | 0.0879 | 0.191 | |
Echinococcus granulosus | lipoxygenase domain containing protein | 0.0021 | 0.0022 | 0.0022 |
Loa Loa (eye worm) | thymidylate synthase | 0.0109 | 0.0879 | 0.195 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase, putative | 0.0052 | 0.032 | 0.163 |
Leishmania major | dihydrofolate reductase-thymidylate synthase | 0.022 | 0.1966 | 1 |
Schistosoma mansoni | loxhd1 | 0.0021 | 0.0022 | 0.0026 |
Schistosoma mansoni | polycystin 1-related | 0.0021 | 0.0022 | 0.0026 |
Giardia lamblia | Kinesin-5 | 0.0135 | 0.1137 | 0.5 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.0402 | 0.0892 |
Echinococcus granulosus | RUN | 0.0021 | 0.0022 | 0.0022 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0066 | 0.0457 | 0.2325 |
Echinococcus granulosus | lipoxygenase domain containing protein | 0.0021 | 0.0022 | 0.0022 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.2592 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | 1.0418 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 4.1475 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 11.2202 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 18.3564 uM | PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 56.2341 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.